
NKGen Biotech Inc (NKGN)
NASDAQ
Fin d'année 31 Décembre 2023 | 2021 | 2022 | 2023 |
---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | |
Return on Assets (%) | -1.138 | 2.61 | -86.932 |
Return on Equity (%) | 18.192 | -60.374 | 263.916 |
Return on Invested Capital (%) | 45.885 | 32.597 | 124.094 |
Operating Margin (%) | N/A | N/A | N/A |
Net Profit Margin (%) | N/A | N/A | N/A |
Book Value Per Share | 37.464 | 7.878 | -2.686 |
Earnings Per Share | -0.231 | 0.212 | -3.79 |
Cash Per Share | 0.402 | 0.03 | 0.001 |
Working Capital Per Share | 0.15 | -0.092 | -1.714 |
Operating Profit Per Share | N/A | N/A | N/A |
EBIT Per Share | -0.231 | 0.232 | -3.789 |
EBITDA Per Share | -0.231 | 0.232 | -3.789 |
Free Cash Flow Per Share | -0.231 | 0.212 | -3.838 |
Fin d'année 31 Décembre 2023 | 2021 | 2022 | 2023 |
---|---|---|---|
Current Ratio | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A |
Actions en circulation | 4,29M | N/A | N/A |
Fin d'année 31 Décembre 2023 | Sept 2022 | Déc 2022 | Mar 2023 | Juin 2023 | Sept 2023 | Déc 2023 | Mar 2024 | Juin 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | ||||||
Actions en circulation | N/A | N/A | 21,45M | N/A | N/A | N/A | N/A | N/A |
Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Net Profit Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Capitalisation boursière | 15,84M |
Ratio cours/bénéfice | -0,24 |
Ratio prix/ventes | 0 |
Ratio prix/liquidités | 800 |
Ratio prix/valeur comptable | -0,34 |
Rendement de dividende | - |
Actions en circulation | 35,36M |
Volume moyen (1 semaine) | 1,25M |
Volume moyen (1 mois) | 4,81M |
Variation sur 52 semaines | -59,35% |
Plus haut sur 52 semaines | 4,06 |
Plus bas sur 52 semaines | 0,2026 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales